Results 111 to 120 of about 3,904 (178)

Effective Management of Recalcitrant Hailey-Hailey Disease With Risankizumab. [PDF]

Int J Dermatol
Justice J, Della Porta A, Niklinska E, Miller JL.   +3 more
europepmc   +1 more source

Risankizumab redefines Crohn's treatment after ustekinumab failure. [PDF]

World J Gastrointest Pharmacol Ther
Omullo FP.
europepmc   +1 more source

Effectiveness, Quality of Life and Durability of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Real-World Evidence from the PRIMMA Study. [PDF]

Dermatol Ther (Heidelb)
Snast I, Valdman-Grinshpoun Y, Bathish N, Matz H, Shclar Y, Murad S, Czarnowicki T, Shavit E, Yang L, Goss S, Maor IP, Halperin A, Blonder SN, Cohen R, Bleterman A, Barak M, Pavlovsky L.   +16 more
europepmc   +1 more source

Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions. [PDF]

J Pers Med
Pool IA, Otten AT, Kosterink JGW, Dijkstra G, Mian P, Bourgonje AR.   +5 more
europepmc   +1 more source

Biological Therapy for Moderate-to-Severe Psoriasis: A 5-Year Analysis of Patients from Lithuania. [PDF]

Medicina (Kaunas)
Indrisiunaite E, Jonaityte IR, Karmaziene T, Raudonis T.   +3 more
europepmc   +1 more source

Efficacy and Safety of Risankizumab in a Patient With Complex Crohn's Disease and a High-Output Ileostomy: A Case Report. [PDF]

Cureus
Zahid SI, Tamimi K, Ansari AK, Zahid NI, Barakat MI.   +4 more
europepmc   +1 more source

A 17-Year-Old Male Adolescent With Refractory Crohn's Disease Managed With Upadacitinib and Risankizumab Combination Therapy: A Case Report and Review of Current Evidence. [PDF]

Am J Case Rep
Alhashemi M, Shehab M.
europepmc   +1 more source

Improvement in small-bowel and colonic lesions observed by intestinal ultrasonography in Crohn's disease treated with risankizumab. [PDF]

Medicine (Baltimore)
Miyakawa M, Nasuno M, Nojima M, Konno A, Shimoyama K, Hamada T, Sugiyama K, Tanaka H.   +7 more
europepmc   +1 more source

IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far? [PDF]

J Inflamm Res
Megna M, D'Agostino M, Feo F, Ventura V, Tommasino N, Potestio L.   +5 more
europepmc   +1 more source

Evaluating Risankizumab's Long-Term Effects in Psoriasis Using Optical Coherence Tomography. [PDF]

Dermatol Ther (Heidelb)
Zirpel H, Ha-Wissel L, Hobelsberger S, Pommerien L, Beissert S, Gaffal E, Bauer R, Neumeister J, Lohmann K, Thaçi D.   +9 more
europepmc   +1 more source